While breast and ovarian cancers are the hallmark malignancies associated with breast cancer (BRCA) mutations, emerging evidence suggests that carriers of BRCA1 and BRCA2 mutations may also face an elevated risk for other cancers, including pancreatic, prostate and, as in some reported cases, cervical cancer [1,3]. This evidence concerns the gene BRCA1 and ovarian carcinoma.